Back
Trinity Biotech PLC Vs. Perspective Therapeutics Industry Stock Comparison
Sell
23
TRIB
Trinity Biotech PLC
Last Price:
2.04
Seasonality Move:
-8.79%
Sell
46
CATX
Perspective Therapeutics
Last Price:
10.70
Seasonality Move:
-0.04%
Sell
23
Trinity Biotech PLC (TRIB)
is a Sell
Is Trinity Biotech PLC a Buy, Sell or Hold?
- The current Trinity Biotech PLC [TRIB] share price is $2.04. The Score for TRIB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- TRIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $10.72. The Score for CATX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRIB Stock Price Chart
What is Trinity Biotech PLC's stock price today?
-
The Trinity Biotech PLC share price today is $2.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $10.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 46.18 | Sell |
Chaikin Money Flow: | -16604 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.68) | Sell |
Bollinger Bands (100): | (1.7 - 2.42) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.97 | Sell |
Relative Strength Index (14 RSI): | 43.23 | Sell |
Chaikin Money Flow: | 572812 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.12 - 13.08) | Sell |
Bollinger Bands (100): | (10.11 - 15.81) | Sell |
TRIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.1 | Sell |
20-day SMA: | 2.39 | Sell |
50-day SMA: | 1.97 | Buy |
200-day SMA: | 2.28 | Sell |
8-day EMA: | 2.15 | Sell |
20-day EMA: | 2.2 | Sell |
50-day EMA: | 2.1 | Sell |
200-day EMA: | 2.52 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.26 | Buy |
20-day SMA: | 11.07 | Sell |
50-day SMA: | 14.05 | Sell |
200-day SMA: | 8.39 | Buy |
8-day EMA: | 10.57 | Buy |
20-day EMA: | 11.28 | Sell |
50-day EMA: | 12.55 | Sell |
200-day EMA: | 9.94 | Buy |
Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $0.29 per share, a decrease this year of $1.77 per share, and an increase next year of $1.13 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Trinity Biotech PLC Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |